The potential bias introduced into COVID-19 vaccine effectiveness studies at primary care level due to the availability of SARS-CoV-2 tests in the general population
- PMID: 40534212
- PMCID: PMC12204317
- DOI: 10.1093/ije/dyaf086
The potential bias introduced into COVID-19 vaccine effectiveness studies at primary care level due to the availability of SARS-CoV-2 tests in the general population
Abstract
Background: With SARS-CoV-2 self-tests, persons with acute respiratory infections (ARI) can know their COVID-19 status. This may alter their decision to consult a general practitioner (GP), potentially biasing COVID-19 vaccine effectiveness (VE) studies. We explore bias mechanisms, simulate magnitude, and verify control methods.
Methods: We used directed acyclic graphs (DAGs) to illustrate the bias mechanisms. Based on the European primary care VEBIS multicentre test-negative design (TND) study, we simulated populations with varying true VE (20%-60%), proportions of persons with ARI self-testing (10%-30%), effect of COVID-19 vaccination on self-testing (1.5-2.5), and effect of self-test result on GP consultation (0.5-2). We performed 5000 runs per scenario, estimating VE among those consulting a GP. We calculated bias as true VE minus mean simulated VE, unadjusted and adjusted for self-testing, using logistic regression.
Results: DAGs suggested collider stratification bias if vaccination had an effect on self-testing and if self-test results affected GP consultation. Bias was -12% to 18% at 20% true VE, with the most extreme associations and 30% self-testing. With 60% true VE and 10%-20% self-testing, bias was lower. Bias was higher (-18% to 45%) if both positive and negative self-test results affected GP consultation. Adjusting for self-testing removed the bias.
Conclusions: Self-testing may bias COVID-19 VE TND studies in primary care if self-testing is high, particularly with low VE. We recommend primary care TND VE studies collect self-testing information to eliminate potential bias. Observational studies are needed to understand the relationship between vaccination, self-testing, and GP consultation, in these studies' source population.
Keywords: COVID-19; SARS-CoV-2; bias; primary health care; self-testing; vaccine effectiveness.
© The Author(s) 2025. Published by Oxford University Press on behalf of the International Epidemiological Association.
Figures
References
-
- Supplisson O, Charmet T, Galmiche S et al. SARS-CoV-2 self-test uptake and factors associated with self-testing during Omicron BA.1 and BA.2 waves in France, January to May 2022. Euro Surveill 2023;28:2200781. https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2023.28.18... - DOI - PMC - PubMed
-
- van Hagen C. The Association between SARS-CoV-2 Rapid Antigen Self-test Use and Healthcare Seeking Behaviour at Primary Care Level. Valencia, Spain: ESWI, 17 September 2023. https://s3.eu-central-1.amazonaws.com/eswi.org/downloads/ESWI2023_abstra... (6 September, date last accessed).
-
- Valenciano M, Ciancio B, I-MOVE Study Team. I-MOVE: a European network to measure the effectiveness of influenza vaccines. Euro Surveill 2012;17:20281. - PubMed
-
- Jackson ML, Nelson JC. The test-negative design for estimating influenza vaccine effectiveness. Vaccine 2013;31:2165–8. - PubMed
-
- Skowronski DM, Janjua NZ, Sabaiduc S et al. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine. J Infect Dis 2014;210:126–37. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
